Clinical Proteomics

Clinical Proteomics (ISSN 1542-6416) is a peer-reviewed journal published by Springer Nature in the United States that bridges the gap between high-throughput proteomic technologies and clinical application. Indexed in the Science Citation Index (SCI), the journal carries a 2022 impact factor of 3.677 and is classified in the third quartile of the Chinese Academy of Sciences ranking for the broad category of Biology. Its scope centers on the translational aspects of proteomics, with particular emphasis on biomarker discovery, elucidation of disease mechanisms, and the advancement of precision medicine across diverse fields such as oncology, cardiovascular disease, and neurodegenerative disorders. By rigorously integrating advanced analytical methods with clinical data, the journal serves a global audience of researchers and clinicians dedicated to translating proteomic insights into tangible medical improvements. While the publication process is known for its strict review standards and high quality, the increasing competitiveness of the field requires submissions to demonstrate significant methodological innovation and strong clinical relevance, ensuring that the research remains at the forefront of rapidly evolving proteomic technologies.